Performance · Research catalogPerformance research material
CJC-1295 / Ipamorelin research peptide
CJC-1295 and Ipamorelin are presented together in the catalog as a paired research material. The repository describes CJC-1295 in relation to GHRH signaling and Ipamorelin in relation to ghrelin-receptor signaling, making the pair relevant to researchers examining growth-hormone-axis pathways. This page focuses on mechanism and literature context without offering protocols, dosing, or human-use guidance.
Catalog price
Size
2mg/2mg · 10 vials
- Availability
- Listed — documentation connected
- Testing status
- CoA available
- Lot / batch
- DEMO-CJCIPAM-A
- Documentation
- View Certificate of Analysis
Shipping information is shown in checkout before payment. For laboratory research use only. Not for human or veterinary consumption.
Documentation status
Certificate of analysis
Independent analytical testing record for CJC-1295 / Ipamorelin, including HPLC purity, LC-MS identity, and visual examination. Review the complete document for method scope and reported results.
Review method coverage, batch identity, and reported analytical results.
Research involving CJC-1295 / Ipamorelin
The CJC-1295 research record in the repository centers on a longer-acting GHRH-analog profile, while Ipamorelin is discussed as a selective ghrelin mimetic. The two names therefore represent distinct signaling questions even though the catalog supplies them as one paired item.
Existing citations include endocrine research measuring growth hormone and IGF-1 responses in controlled study settings. Those findings describe study measurements and do not establish a consumer outcome or a recommended use for this catalog material.
The product record lists 2 mg/2 mg · 10 vials. No source-linked laboratory report is connected to this product record yet. Synthetic interface references are clearly labelled and are not testing evidence.
Quality and testing
Lot-specific analytical documentation is attached to this product record. The report covers chromatographic purity, identity, visual examination, with additional tests listed in the document.
CJC-1295 / Ipamorelin specifications
| Form | Lyophilized powder |
| Amount | 2 mg/2 mg · 10 vials |
| Catalog category | Performance |
| Intended use | Laboratory research only |
Storage and handling
Unopened lyophilized material should be stored refrigerated at 2–8°C. For long-term storage, maintain at −20°C. Protect from light. Reconstituted solutions should be used promptly or aliquoted and frozen at −20°C. Avoid repeated freeze-thaw cycles.
For laboratory research use only. Not for human or veterinary consumption. Handle in accordance with institutional safety protocols.
How CJC-1295 / Ipamorelin is studied
CJC-1295 / Ipamorelin appears in endocrine and receptor-signaling research. Studies may measure hormone-axis markers, receptor activity, or time-dependent response patterns in controlled models. The page intentionally excludes protocols, doses, administration instructions, and human-use guidance.
CJC-1295 / Ipamorelin FAQs
Why are CJC-1295 and Ipamorelin listed together?
The catalog treats them as one paired research material because the repository discusses their different relationships to GHRH and ghrelin-receptor signaling.
What research areas include this pair?
The existing research context covers growth-hormone-axis signaling, endocrine measurement, GHRH-related activity, and ghrelin-receptor research.
What quantity is listed?
The current catalog lists 2 mg/2 mg · 10 vials.
Is a product-specific COA available?
Not yet. A source-linked Certificate of Analysis is not connected in the current catalog. Synthetic interface references are clearly labelled and are not testing evidence.
Is this product for human or veterinary use?
No. It is presented for laboratory research only and is not for human or veterinary consumption.